Literature DB >> 14570734

Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan.

T Imamura1, O Yokosuka, T Kurihara, T Kanda, K Fukai, F Imazeki, H Saisho.   

Abstract

BACKGROUND: Although it has been reported that different hepatitis B virus (HBV) genotypes induce different clinical characteristics in patients with chronic liver diseases (CLD), there have been few reports that have detailed the distribution of HBV genotypes in acute forms of liver disease.
METHODS: HBV genotypes were determined in 61 patients who had acute forms of liver disease (45 had acute self limited hepatitis (AH) and 16 had fulminant hepatitis (FH)) and in 531 patients with CLD, including 19 patients with severe acute exacerbation of CLD. We also analysed the enhancer II, core promoter, and precore region sequences for the presence of mutations.
RESULTS: Expression of genotype B in patients with acute forms of liver disease was significantly greater than in those with CLD (39.3% v 11.7%, respectively; p<0.001). Furthermore, expression of genotype B was significantly greater in patients with FH than in those with AH (62.5% v 31.1%, respectively; p=0.027). The precore mutation A1896 and the core promoter mutation at nt 1753 and 1754 were found more frequently in FH than in AH, and genotype B was predominant in FH regardless of the presence of these mutations.
CONCLUSIONS: HBV genotype B was found more frequently in patients with acute forms of liver disease than in patients with CLD, and more frequently in patients with FH than in those with AH. These results suggest that this HBV genotype may induce more severe liver damage than other viral genotypes, at least in patients from Chiba, Japan.

Entities:  

Mesh:

Year:  2003        PMID: 14570734      PMCID: PMC1773865          DOI: 10.1136/gut.52.11.1630

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group.

Authors:  E Orito; M Mizokami; H Sakugawa; K Michitaka; K Ishikawa; T Ichida; T Okanoue; H Yotsuyanagi; S Iino
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

2.  Hepatitis B virus genotypes and hepatocellular carcinoma in Japan.

Authors:  H Fujie; K Moriya; Y Shintani; H Yotsuyanagi; S Iino; K Koike
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

3.  Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity.

Authors:  C Grandjacques; P Pradat; L Stuyver; M Chevallier; P Chevallier; C Pichoud; M Maisonnas; C Trépo; F Zoulim
Journal:  J Hepatol       Date:  2000-09       Impact factor: 25.083

4.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

5.  Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa.

Authors:  S O Odemuyiwa; M N Mulders; O I Oyedele; S O Ola; G N Odaibo; D O Olaleye; C P Muller
Journal:  J Med Virol       Date:  2001-11       Impact factor: 2.327

6.  Hepatitis B genotypes and the response to interferon therapy.

Authors:  J H Kao; N H Wu; P J Chen; M Y Lai; D S Chen
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

7.  Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China.

Authors:  X Ding; M Mizokami; G Yao; B Xu; E Orito; R Ueda; M Nakanishi
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

8.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

9.  Hepatitis B virus infection in Thai children.

Authors:  C A Kozik; D W Vaughn; R Snitbhan; B L Innis
Journal:  Trop Med Int Health       Date:  2000-09       Impact factor: 2.622

10.  Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection.

Authors:  A Honda; O Yokosuka; K Suzuki; H Saisho
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

View more
  35 in total

1.  Concerns regarding thrombophilia testing.

Authors:  David Green
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Authors:  Takashi Hoshino; Hitoshi Takagi; Yuhei Suzuki; Atsushi Naganuma; Ken Sato; Satoru Kakizaki; Tsutomu Nishizawa; Hiroaki Okamoto; Masanobu Yamada
Journal:  Clin J Gastroenterol       Date:  2016-05-10

3.  Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Authors:  Mayur Brahmania; Manuel Lombardero; Bettina E Hansen; Norah A Terrault; Anna S Lok; Robert P Perrillo; Steven H Belle; Adrian M Di Bisceglie; Jordan J Feld; William M Lee; Michael W Fried; Harry L A Janssen
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-08       Impact factor: 11.382

4.  Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.

Authors:  Nami Mori; Fumitaka Suzuki; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saito; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-02-29       Impact factor: 7.527

5.  Management of hepatitis B virus-related acute liver failure.

Authors:  Makoto Oketani; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi
Journal:  Clin J Gastroenterol       Date:  2014-01-24

6.  Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.

Authors:  Xueyuan Nian; Zhihui Xu; Yan Liu; Jianhong Chen; Xiaodong Li; Dongping Xu
Journal:  Hepatol Int       Date:  2016-03-16       Impact factor: 6.047

Review 7.  Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.

Authors:  Osamu Yokosuka; Makoto Arai
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

8.  Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection.

Authors:  Shigehiko Sainokami; Koichi Abe; Akihiro Sato; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki; Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

9.  Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation.

Authors:  Yi-Hsing Chen; Sheng-Nan Lu; Jing-Hung Wang; Chao-Hung Hung; Tsung-Hui Hu; Chien-Hung Chen
Journal:  Dig Dis Sci       Date:  2019-03-05       Impact factor: 3.199

Review 10.  Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Masato Nakamura; Tatsuo Miyamura; Shingo Nakamoto; Arup Banerjee; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.